ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology
- Author
- Healthegy
- Published
- Thu 11 Aug 2016
- Episode Link
- None
ReVision Optics built it – a corneal inlay capable of correcting presbyopia. The FDA approved it sooner than expected. Now the company needs to build it into a successful private-pay business.
